Inhibition of autophagy significantly increases the antitumor effect of Abiraterone in prostate cancer.
Ashkan MortezaviSouzan SalemiBenedikt KranzbühlerOliver GrossTullio SulserHans-Uwe SimonDaniel EberliPublished in: World journal of urology (2018)
AA activates autophagy as a cytoprotective mechanism in LNCaP prostate cancer cells and targeting of autophagy enhances the antitumor effect of the compound.